Zorzi Alessandro, Bondarev Sergei, Graziano Francesca, Cecere Annagrazia, Giordani Andrea, Turk Luka, Corrado Domenico, Zucchetta Pietro, Cecchin Diego
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Unit of Nuclear Medicine, Department of Medicine, Università University Hospital of Padova, 35128 Padua, Italy.
J Cardiovasc Dev Dis. 2024 Oct 3;11(10):306. doi: 10.3390/jcdd11100306.
Athletes with heart disease are at increased risk of malignant ventricular arrhythmias and sudden cardiac death compared to their sedentary counterparts. When athletes have symptoms or abnormal findings at preparticipation screenings, a precise diagnosis by differentiating physiological features of the athlete's heart from pathological signs of cardiac disease is as important as it is challenging. While traditional imaging methods such as echocardiography, cardiac magnetic resonance, and computed tomography are commonly employed, nuclear medicine offers unique advantages, especially in scenarios requiring stress-based functional evaluation. This article reviews the use of nuclear medicine techniques in the diagnostic work-up of athletes with suspected cardiac diseases by highlighting their ability to investigate myocardial perfusion, metabolism, and innervation. The article discusses the application of single photon emission computed tomography (SPECT) and positron emission tomography (PET) using radiotracers such as [99mTc]MIBI, [99mTc]HDP, [18F]FDG, and [123I]MIBG. Several clinical scenarios are explored, including athletes with coronary atherosclerosis, congenital coronary anomalies, ventricular arrhythmias, and non-ischemic myocardial scars. Radiation concerns are addressed, highlighting that modern SPECT and PET equipment significantly reduces radiation doses, making these techniques safer for young athletes. We conclude that, despite being underutilized, nuclear medicine provides unique opportunities for accurate diagnosis and effective management of cardiac diseases in athletes.
与久坐不动的同龄人相比,患有心脏病的运动员发生恶性室性心律失常和心源性猝死的风险更高。当运动员在赛前筛查中有症状或异常发现时,通过区分运动员心脏的生理特征与心脏病的病理体征来进行精确诊断既重要又具有挑战性。虽然超声心动图、心脏磁共振和计算机断层扫描等传统成像方法被普遍使用,但核医学具有独特优势,尤其是在需要基于负荷的功能评估的情况下。本文通过强调核医学技术在研究心肌灌注、代谢和神经支配方面的能力,综述了其在疑似心脏病运动员诊断检查中的应用。文章讨论了使用[99mTc]MIBI、[99mTc]HDP、[18F]FDG和[123I]MIBG等放射性示踪剂的单光子发射计算机断层扫描(SPECT)和正电子发射断层扫描(PET)的应用。探讨了几种临床情况,包括患有冠状动脉粥样硬化、先天性冠状动脉异常、室性心律失常和非缺血性心肌瘢痕的运动员。文中还讨论了辐射问题,强调现代SPECT和PET设备显著降低了辐射剂量,使这些技术对年轻运动员更安全。我们得出结论,尽管核医学的应用未得到充分利用,但它为准确诊断和有效管理运动员的心脏病提供了独特机会。